Curcummatrix™ offers a patented technology designed to specifically increase the bioavailability. The improvement solubility was achieved through the pre-formulation of potential micro-emulsions, in the digestive system, after disintegration of the capsule. The presence of a high Hydrophilic-Lipophilic Balance emulsifier combined with curcumin in a defined ratio enabled the greatly enhanced solubility.
Curcummatrix™ offers a solubility in duodenal conditions 7.5 times greater than the same amount of native curcumin. Compared to soy lecithin based curcumin, Curcummatrix™ is five times more bioavailable (50ng/ml vs 333ng/ml).
Each gelcap contains:
|Tumeric Rhizome Extract (curcuma Longa L, 60:1)||42 mg (DHE 2,520 mg)|